SVB Financial Group

SEC CIK: 0000719739
Latest filing: Nov 10, 2025

SEC filings (opens in a new tab)

KNTE holding history

Kinnate Biopharma Inc. in every 13F filed by SVB Financial Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KNTE overview All 13F holders of KNTE Full Q3 2025 holdings

Shares (Q2 2023): 0; Sold out in Q2 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2022

Holdings of KNTE by SVB Financial Group, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2023	0	$0	0.0%	−15,588−100.0%	Sold out	Holders
Q1 2023	15,588	$97.4K	0.2%	−7,794−33.3%	Reduced	Holders
Q4 2022	23,382	$142.6K	0.4%	–	No prior filing	Holders